Molecular Diversity of Embryonic-Type Neuroectodermal Tumors Arising From Testicular Germ Cell Tumors

Yang Zong1, Rongrong Huang2, Mireille Bitar3

  • 1Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California; Now with Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin.

Insights

Embryonic-type neuroectodermal tumors (ENTs) from testicular germ cell tumors (GCTs) show distinct molecular profiles. Genomic analysis reveals two main subtypes: one with MYCN/MYC amplification and p53 pathway inactivation, the other with PI3K pathway activation.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • Embryonic-type neuroectodermal tumors (ENTs) are a somatic transformation of testicular germ cell tumors (GCTs).
  • These tumors have a poor prognosis and limited treatment options, especially upon recurrence or metastasis.
  • Comprehensive genomic data on GCT-derived ENTs is scarce, hindering understanding of their development.

Purpose of the Study:

  • To investigate the molecular features of testicular GCT-derived ENTs.
  • To identify key genetic alterations driving the transformation from GCTs to ENTs.
  • To stratify these tumors based on distinct molecular profiles.

Main Methods:

  • Retrospective analysis of 10 testicular GCT-derived ENTs.
  • Next-generation sequencing-based comprehensive genomic profiling.
  • Central rereview of clinicopathological and genomic data.

Main Results:

  • All tumors showed chromosome 12p gain, supporting GCT origin, with frequent KRAS, CCND2, and KMD5A coamplification.
  • Two distinct molecular subtypes were identified: 1) MYCN/MYC amplification with p53 pathway inactivation (TP53 mutation or MDM2 amplification) in 30% of tumors, and 2) PI3K pathway activation (PIK3CA/PIK3CG mutations or PIK3C2B amplification) in 30%, sometimes with CDK4 amplification.
  • Novel gene fusions (BRD4::MAU2, BCOR::CLIP2) and an ATRX rearrangement were detected in 30% of tumors.
  • Tumors were microsatellite-stable with low tumor mutational burden.

Conclusions:

  • Testicular GCT-derived ENTs are molecularly diverse but can be classified into two main genetic alteration groups.
  • These findings highlight potential common tumorigenic events between ENTs from different anatomical sites.
  • Further research into these molecular subtypes may lead to targeted therapeutic strategies.

Related Concept Videos